Because the Mitral Touch device can be implanted on a beating heart, surgeons are empowered to use a ‘hands-on’ approach. Patients benefit from a surgeon’s knowledge of the variation of the left ventricular and atrial geometries, resulting in more precise device placement and optimal MR reduction outcomes.
Initial clinical studies have been performed on patients needing mitral valve repair during CABG surgery. Experience from initial clinical procedures has shown that implantation of the Mitral Touch device should take less than 30 minutes.